Walder Wyss has taken on the role of data protection officer advisor of Swisstransplant. In this capacity, the firm supports Swisstransplant in conducting data protection assessments and implementing measures to ensure compliance under the upcoming
Scaled Agile, a portfolio company of Eurazeo SE, one of Europe’s leading private equity firms, has acquired Rentouch, a Swiss-based company specializing in software for visualizing agile planning events across multiple agile teams with
The listed Austrian Semperit Aktiengesellschaft Holding has acquired RICO Group from its founders. The Semperit Group is a global maker of specialized polymer products for industrial applications, including hoses and belts. The RICO Group consists
The Swiss Financial Market Supervisory Authority FINMA approved the application of Trident Trust as trustee under the Financial Institutions Act (FINIA). Trident Trust Group was founded in 1978 and is a leading independent provider of corporate,
Mosanna Therapeutics, a Basel-based biotechnology company developing the highly differentiated small molecule MOS118 for the treatment of metabolic obstructive sleep apnea, has closed an extension of the Seed Financing Round with the investors Supermoon Capital,
Kellerhals Carrard has advised ETH Zurich spin-off OPTIML, a fast-growing AI startup focused on revolutionizing sustainable real estate, in its successful pre-seed round. The round was co-led by Innovation Endeavors and Planet A Ventures with
Altenburger strengthens its team with the incorporation of Kristin Arve (pictured left) and Nicola Zehnder (pictured right) as associates. Arve is part of Altenburger’s Dispute Resolution Team. She mainly deals with civil and commercial
GOLDBEK Holding, a fast growing and innovative German greeting card publishing company, has acquired 100% of ABC Kunst- und Glückwunschkartenverlag (its legal name is A. Boss & Co), a privately owned Swiss market leader in
Samsung Ventures has made a strategic investment in Araris Biotech. The investment corporation, that was established to promote the development of new technologies, has invested in the company in an independent deal ahead of its
ATANIS Biotech, a Swiss biotechnology company specializing in functional allergy diagnosis, announced the successful completion of a significant capital increase. iXLife, a French venture capital fund, co-led the round with US-based AllerFund, the first and
